September 20, 2019- We are excited to announce that Exagen joins our recent group of IPO’s! In the last 4 years we’ve seen Instructure, Everspin, Health Catalyst and now Exagen join this elite group. We are proud to partner with Exagen in their mission of ” transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention.”
Exagen is our third exit from the New Mexico ecosystem, preceded by Lavu (Point of Sale solution) and Lumidigm, Inc. (acquired by HID Global).
Source url: Globe Newswire